2014 Article Archive
Researchers target the cell’s ‘biological clock’ in promising new therapy to kill cancer cells, shrink tumor growth
Cell biologists at UT Southwestern Medical Center have targeted telomeres with a small molecule called 6-thiodG that takes advantage of the cell’s ‘biological clock’ to kill cancer cells and shrink tumor growth.
Stereotactic body radiation therapy plus chemotherapy improves survival among stage 4 lung cancer patients
A clinical trial that combined stereotactic body radiation therapy with a specific chemotherapy regimen more than doubled survival rates for certain stage 4 lung cancer patients
UT Southwestern Medical Center cancer researchers have demonstrated that whole-genome sequencing can be used to identify patients’ risk for hereditary cancer.
The American Association for the Advancement of Science (AAAS) recently announced the selection of UT Southwestern Medical Center Professor of Biochemistry Dr. Jef K. De Brabander as a Fellow.
UT Southwestern Medical Center has announced the appointment of Steve Moore as Vice President for Communications, Marketing, and Public Affairs.
A year ago, Dr. Olutoyosi “Toy” Ogunkua, now a third-year resident in anesthesiology, was interested in meeting other trainees particularly those outside his specialty. Then, he found his way to HEAL.
The UT System Board of Regents has approved creation of the Alfred G. Gilman Distinguished Chair in Pharmacology, which honors the 1994 Nobel Laureate’s numerous contributions to UT Southwestern Medical Center.
National trial first to focus on long-term complications associated with chronic kidney disease, diabetes, hypertension
UT Southwestern will lead the first National Institutes of Health-funded, multicenter, clinical trial to address interventions for patients with multiple chronic conditions centered around kidney disease.
Researchers at UT Southwestern and Karolinska Institutet in Stockholm, Sweden, found that endogenous retroviruses (ERV) play a critical role in the body’s immune defense against common bacterial and viral pathogens.
UT Southwestern Medical Center researchers have discovered that brain tumors are capable of burning acetate for fuel, providing a new potential target for halting tumor growth.